Synergy scores were normalized using Min-Max Scaling to facilitate visual comparisons.
DrugCom Name |
DrugCom ID |
Component Drug |
Indication |
REF |
Acitretin + Artemisinin
|
DC3ZZTL
|
Acitretin
|
Chronic myelogenous leukemia (Cell Line: KBM-7)
|
[2] |
Artemether + Artemisinin
|
DC7WTX0
|
Artemether
|
Hepatoblastoma (Cell Line: HB3)
|
[2] |
Artemisinin + Aprepitant
|
DCMRXTC
|
Aprepitant
|
Chronic myelogenous leukemia (Cell Line: KBM-7)
|
[2] |
Artemisinin + Meclofenamic acid
|
DC138IF
|
Meclofenamic acid
|
Chronic myelogenous leukemia (Cell Line: KBM-7)
|
[2] |
Artemisinin + Baclofen
|
DCDGCBO
|
Baclofen
|
Chronic myelogenous leukemia (Cell Line: KBM-7)
|
[2] |
Artemisinin + Bepridil
|
DC0MET7
|
Bepridil
|
Chronic myelogenous leukemia (Cell Line: KBM-7)
|
[2] |
Artemisinin + Gefitinib
|
DCKGDCS
|
Gefitinib
|
Chronic myelogenous leukemia (Cell Line: KBM-7)
|
[2] |
Artemisinin + Paromomycin
|
DCESJVM
|
Paromomycin
|
Chronic myelogenous leukemia (Cell Line: KBM-7)
|
[2] |
Artemisinin + Dantrolene
|
DC5X981
|
Dantrolene
|
Chronic myelogenous leukemia (Cell Line: KBM-7)
|
[2] |
Artemisinin + OZ277
|
DCM60H5
|
OZ277
|
Hepatoblastoma (Cell Line: HB3)
|
[2] |
Artemisinin + Trametinib
|
DCCTRXK
|
Trametinib
|
DD2 (Cell Line: DD2)
|
[2] |
Artemisinin + Dactinomycin
|
DCQZWM5
|
Dactinomycin
|
Hepatoblastoma (Cell Line: HB3)
|
[2] |
Artemisinin + Epinephrine
|
DC0FKRN
|
Epinephrine
|
Chronic myelogenous leukemia (Cell Line: KBM-7)
|
[2] |
Artemisinin + Artemether
|
DCTW8IV
|
Artemether
|
DD2 (Cell Line: DD2)
|
[2] |
Artemisinin + Artemether
|
DC1HZUT
|
Artemether
|
Hepatoblastoma (Cell Line: HB3)
|
[2] |
Artemisinin + AC265347
|
DCS6XOU
|
AC265347
|
DD2 (Cell Line: DD2)
|
[2] |
Artemisinin + Panobinostat
|
DC03P8P
|
Panobinostat
|
DD2 (Cell Line: DD2)
|
[2] |
Artemisinin + Panobinostat
|
DCGJYZO
|
Panobinostat
|
Hepatoblastoma (Cell Line: HB3)
|
[2] |
Artemisinin + BIX-01294
|
DCPRUEK
|
BIX-01294
|
DD2 (Cell Line: DD2)
|
[2] |
Artemisinin + BIX-01294
|
DCQJFWT
|
BIX-01294
|
Hepatoblastoma (Cell Line: HB3)
|
[2] |
Artemisinin + Ym155
|
DCO9EOF
|
Ym155
|
DD2 (Cell Line: DD2)
|
[2] |
Artemisinin + Ym155
|
DCNZMUQ
|
Ym155
|
Hepatoblastoma (Cell Line: HB3)
|
[2] |
Artemisinin + Anamorelin
|
DC09RRB
|
Anamorelin
|
Chronic myelogenous leukemia (Cell Line: KBM-7)
|
[2] |
Artemisinin + Alvespimycin hydrochloride
|
DC6B3P0
|
Alvespimycin hydrochloride
|
DD2 (Cell Line: DD2)
|
[2] |
Artemisinin + MK-3207
|
DCPVYHZ
|
MK-3207
|
Hepatoblastoma (Cell Line: HB3)
|
[2] |
Artemisinin + Ezetimibe
|
DCDYC6F
|
Ezetimibe
|
Chronic myelogenous leukemia (Cell Line: KBM-7)
|
[2] |
Artemisinin + Azelnidipine
|
DCQA4PK
|
Azelnidipine
|
DD2 (Cell Line: DD2)
|
[2] |
Artemisinin + IT-141
|
DCJATG9
|
IT-141
|
Chronic myelogenous leukemia (Cell Line: KBM-7)
|
[2] |
Artemisinin + Buspirone
|
DCL8GI4
|
Buspirone
|
Chronic myelogenous leukemia (Cell Line: KBM-7)
|
[2] |
Artemisinin + Metyrosine
|
DC39ZOF
|
Metyrosine
|
Chronic myelogenous leukemia (Cell Line: KBM-7)
|
[2] |
Artemisinin + Terameprocol
|
DCTAQ37
|
Terameprocol
|
Chronic myelogenous leukemia (Cell Line: KBM-7)
|
[2] |
Artemisinin + Torin2
|
DCX636T
|
Torin2
|
Hepatoblastoma (Cell Line: HB3)
|
[2] |
Artemisinin + Elesclomol
|
DCLLTBK
|
Elesclomol
|
DD2 (Cell Line: DD2)
|
[2] |
Artemisinin + Ursodeoxycholic acid
|
DCX4MB8
|
Ursodeoxycholic acid
|
Chronic myelogenous leukemia (Cell Line: KBM-7)
|
[2] |
Artemisinin + Docetaxel
|
DC204W2
|
Docetaxel
|
Chronic myelogenous leukemia (Cell Line: KBM-7)
|
[2] |
Artemisinin + Docetaxel
|
DCMNR9G
|
Docetaxel
|
DD2 (Cell Line: DD2)
|
[2] |
Artemisinin + Docetaxel
|
DCO6SVE
|
Docetaxel
|
Hepatoblastoma (Cell Line: HB3)
|
[2] |
Artemisinin + Phenprocoumon
|
DCQ9HXF
|
Phenprocoumon
|
Chronic myelogenous leukemia (Cell Line: KBM-7)
|
[2] |
Artemisinin + ETHISTERONE
|
DCOUR44
|
ETHISTERONE
|
Chronic myelogenous leukemia (Cell Line: KBM-7)
|
[2] |
Artemisinin + Methoxsalen
|
DCV83IG
|
Methoxsalen
|
Chronic myelogenous leukemia (Cell Line: KBM-7)
|
[2] |
Artemisinin + Galantamine
|
DC4REB4
|
Galantamine
|
Chronic myelogenous leukemia (Cell Line: KBM-7)
|
[2] |
Artemisinin + VR-776
|
DCA2JZ1
|
VR-776
|
Chronic myelogenous leukemia (Cell Line: KBM-7)
|
[2] |
Artemisinin + Armodafinil
|
DCH4ZCI
|
Armodafinil
|
Chronic myelogenous leukemia (Cell Line: KBM-7)
|
[2] |
Artemisinin + Cycloheximide
|
DCD9YIX
|
Cycloheximide
|
DD2 (Cell Line: DD2)
|
[2] |
Artemisinin + Cycloheximide
|
DCGMTL3
|
Cycloheximide
|
Hepatoblastoma (Cell Line: HB3)
|
[2] |
Artemisinin + Fendiline
|
DC2HYFK
|
Fendiline
|
DD2 (Cell Line: DD2)
|
[2] |
Artemisinin + Diphenidol
|
DCDH9WB
|
Diphenidol
|
Chronic myelogenous leukemia (Cell Line: KBM-7)
|
[2] |
Artemisinin + Pentamidine
|
DC9J3TT
|
Pentamidine
|
Chronic myelogenous leukemia (Cell Line: KBM-7)
|
[2] |
Artemisinin + Sulfapyridine
|
DC7GFNG
|
Sulfapyridine
|
Chronic myelogenous leukemia (Cell Line: KBM-7)
|
[2] |
Artemisinin + Triflupromazine
|
DCE8SJE
|
Triflupromazine
|
Chronic myelogenous leukemia (Cell Line: KBM-7)
|
[2] |
Artemisinin + Niclosamide
|
DCDZEHW
|
Niclosamide
|
Chronic myelogenous leukemia (Cell Line: KBM-7)
|
[2] |
Artemisinin + PF-02545920
|
DCXI9N2
|
PF-02545920
|
Chronic myelogenous leukemia (Cell Line: KBM-7)
|
[2] |
Artemisinin + Trifluoperazine
|
DCFO40C
|
Trifluoperazine
|
Chronic myelogenous leukemia (Cell Line: KBM-7)
|
[2] |
Artemisinin + Trifluoperazine
|
DCOWHZY
|
Trifluoperazine
|
DD2 (Cell Line: DD2)
|
[2] |
Artemisinin + Tiagabine
|
DCTSB0X
|
Tiagabine
|
Chronic myelogenous leukemia (Cell Line: KBM-7)
|
[2] |
Artemisinin + Ibutilide
|
DCUVK19
|
Ibutilide
|
Chronic myelogenous leukemia (Cell Line: KBM-7)
|
[2] |
Artemisinin + Tamoxifen
|
DCDNJP7
|
Tamoxifen
|
Chronic myelogenous leukemia (Cell Line: KBM-7)
|
[2] |
Artemisinin + Idarubicin
|
DC70SU9
|
Idarubicin
|
Glioblastoma? (Cell Line: T98G)
|
[2] |
Artemisinin + Methocarbamol
|
DCPZZDL
|
Methocarbamol
|
Chronic myelogenous leukemia (Cell Line: KBM-7)
|
[2] |
Artemisinin + Probenecid
|
DCCC89Z
|
Probenecid
|
Chronic myelogenous leukemia (Cell Line: KBM-7)
|
[2] |
Artemisinin + Abacavir
|
DCJIUXI
|
Abacavir
|
Chronic myelogenous leukemia (Cell Line: KBM-7)
|
[2] |
Artemisinin + Darunavir
|
DCVFUOH
|
Darunavir
|
Chronic myelogenous leukemia (Cell Line: KBM-7)
|
[2] |
Artemisinin + Atenolol
|
DCW6TC7
|
Atenolol
|
Chronic myelogenous leukemia (Cell Line: KBM-7)
|
[2] |
Artemisinin + Bortezomib
|
DCASH2E
|
Bortezomib
|
DD2 (Cell Line: DD2)
|
[2] |
Artemisinin + Acamprosate
|
DCWGS2Z
|
Acamprosate
|
Chronic myelogenous leukemia (Cell Line: KBM-7)
|
[2] |
Artemisinin + Moricizine
|
DCXEC4M
|
Moricizine
|
Hepatoblastoma (Cell Line: HB3)
|
[2] |
Artemisinin + Artemisinin
|
DCD11IJ
|
Artemisinin
|
DD2 (Cell Line: DD2)
|
[2] |
Artemisinin + Clascoterone
|
DC0CRWW
|
Clascoterone
|
Chronic myelogenous leukemia (Cell Line: KBM-7)
|
[2] |
Artemisinin + Trimethobenzamide
|
DCR1NIR
|
Trimethobenzamide
|
Chronic myelogenous leukemia (Cell Line: KBM-7)
|
[2] |
Artemisinin + Omacetaxine mepesuccinate
|
DCQH6LL
|
Omacetaxine mepesuccinate
|
DD2 (Cell Line: DD2)
|
[2] |
Artemisinin + Omacetaxine mepesuccinate
|
DCXM83L
|
Omacetaxine mepesuccinate
|
Hepatoblastoma (Cell Line: HB3)
|
[2] |
Artemisinin + Maprotiline
|
DCOLCR1
|
Maprotiline
|
Chronic myelogenous leukemia (Cell Line: KBM-7)
|
[2] |
Artemisinin + Oxyphenbutazone
|
DCNL92C
|
Oxyphenbutazone
|
Chronic myelogenous leukemia (Cell Line: KBM-7)
|
[2] |
Artemisinin + 1-((2-chlorophenyl)diphenylmethyl)-1H-pyrazole
|
DCK4225
|
1-((2-chlorophenyl)diphenylmethyl)-1H-pyrazole
|
Chronic myelogenous leukemia (Cell Line: KBM-7)
|
[2] |
Artemisinin + Lacidipine
|
DC5XJWK
|
Lacidipine
|
DD2 (Cell Line: DD2)
|
[2] |
Artemisinin + Theophylline
|
DCBP8IA
|
Theophylline
|
Chronic myelogenous leukemia (Cell Line: KBM-7)
|
[2] |
Artemisinin + Chlorambucil
|
DCJWYC5
|
Chlorambucil
|
Chronic myelogenous leukemia (Cell Line: KBM-7)
|
[2] |
Artemisinin + Quinine
|
DCV19DW
|
Quinine
|
Chronic myelogenous leukemia (Cell Line: KBM-7)
|
[2] |
Artemisinin + Endoxifen
|
DCQIRAC
|
Endoxifen
|
Chronic myelogenous leukemia (Cell Line: KBM-7)
|
[2] |
Artemisinin + NVP-AUY922
|
DCLC8Q3
|
NVP-AUY922
|
Hepatoblastoma (Cell Line: HB3)
|
[2] |
Artemisinin + Mycophenolic acid
|
DCP7JD6
|
Mycophenolic acid
|
Chronic myelogenous leukemia (Cell Line: KBM-7)
|
[2] |
Artemisinin + Oxandrolone
|
DC2FBHM
|
Oxandrolone
|
Chronic myelogenous leukemia (Cell Line: KBM-7)
|
[2] |
Artemisinin + Cyclosporin A
|
DCBMOE7
|
Cyclosporin A
|
DD2 (Cell Line: DD2)
|
[2] |
Artemisinin + Pizotyline
|
DCPXGAW
|
Pizotyline
|
Chronic myelogenous leukemia (Cell Line: KBM-7)
|
[2] |
Artemisinin + Zileuton
|
DCK04E4
|
Zileuton
|
Chronic myelogenous leukemia (Cell Line: KBM-7)
|
[2] |
Artemisinin + Nabilone
|
DCWNNER
|
Nabilone
|
Chronic myelogenous leukemia (Cell Line: KBM-7)
|
[2] |
Artemisinin + Silver sulfadiazine
|
DC1QS80
|
Silver sulfadiazine
|
Chronic myelogenous leukemia (Cell Line: KBM-7)
|
[2] |
Artemisinin + PPADS
|
DCHLY28
|
PPADS
|
DD2 (Cell Line: DD2)
|
[2] |
Artemisinin + Vorinostat
|
DC9GJX6
|
Vorinostat
|
Chronic myelogenous leukemia (Cell Line: KBM-7)
|
[2] |
Artemisinin + Estramustine
|
DCIFKV6
|
Estramustine
|
Chronic myelogenous leukemia (Cell Line: KBM-7)
|
[2] |
Artemisinin + Atovaquone
|
DCGHQG0
|
Atovaquone
|
Chronic myelogenous leukemia (Cell Line: KBM-7)
|
[2] |
Artemisinin + Enoxacin
|
DC9RJBV
|
Enoxacin
|
Chronic myelogenous leukemia (Cell Line: KBM-7)
|
[2] |
Artemisinin + Acetohydroxamic Acid
|
DCH1ZE1
|
Acetohydroxamic Acid
|
Chronic myelogenous leukemia (Cell Line: KBM-7)
|
[2] |
Artemisinin + Albendazole
|
DC2PEXL
|
Albendazole
|
Chronic myelogenous leukemia (Cell Line: KBM-7)
|
[2] |
Atovaquone + Artemisinin
|
DCZLWQ9
|
Atovaquone
|
DD2 (Cell Line: DD2)
|
[2] |
Atovaquone + Artemisinin
|
DCFUHW2
|
Atovaquone
|
Hepatoblastoma (Cell Line: HB3)
|
[2] |
Auranofin + Artemisinin
|
DCI3QVT
|
Auranofin
|
Chronic myelogenous leukemia (Cell Line: KBM-7)
|
[2] |
Azelnidipine + Artemisinin
|
DCJ1ESB
|
Azelnidipine
|
DD2 (Cell Line: DD2)
|
[2] |
Azelnidipine + Artemisinin
|
DC4QGJH
|
Azelnidipine
|
Hepatoblastoma (Cell Line: HB3)
|
[2] |
BIO-300 + Artemisinin
|
DC0A1KY
|
BIO-300
|
Chronic myelogenous leukemia (Cell Line: KBM-7)
|
[2] |
BIX-01294 + Artemisinin
|
DCXKFWT
|
BIX-01294
|
DD2 (Cell Line: DD2)
|
[2] |
BIX-01294 + Artemisinin
|
DCP46F0
|
BIX-01294
|
Hepatoblastoma (Cell Line: HB3)
|
[3] |
Bumetanide + Artemisinin
|
DC6AAPQ
|
Bumetanide
|
DD2 (Cell Line: DD2)
|
[2] |
Carfilzomib + Artemisinin
|
DC2DTWZ
|
Carfilzomib
|
DD2 (Cell Line: DD2)
|
[2] |
Carfilzomib + Artemisinin
|
DC15SJL
|
Carfilzomib
|
Hepatoblastoma (Cell Line: HB3)
|
[2] |
Carvedilol + Artemisinin
|
DCIK82N
|
Carvedilol
|
DD2 (Cell Line: DD2)
|
[2] |
Cefmenoxime + Artemisinin
|
DCDURQI
|
Cefmenoxime
|
Chronic myelogenous leukemia (Cell Line: KBM-7)
|
[2] |
Cerivastatin + Artemisinin
|
DC1F4PN
|
Cerivastatin
|
Chronic myelogenous leukemia (Cell Line: KBM-7)
|
[2] |
Chlormezanone + Artemisinin
|
DCPLHRF
|
Chlormezanone
|
Chronic myelogenous leukemia (Cell Line: KBM-7)
|
[2] |
Chloroquine + Artemisinin
|
DCBPG21
|
Chloroquine
|
Hepatoblastoma (Cell Line: HB3)
|
[2] |
Chlorphenesin + Artemisinin
|
DCIB5QR
|
Chlorphenesin
|
Chronic myelogenous leukemia (Cell Line: KBM-7)
|
[2] |
Chlorzoxazone + Artemisinin
|
DCA8ID6
|
Chlorzoxazone
|
Chronic myelogenous leukemia (Cell Line: KBM-7)
|
[2] |
Cilostazol + Artemisinin
|
DCUJDE5
|
Cilostazol
|
Chronic myelogenous leukemia (Cell Line: KBM-7)
|
[2] |
Cycloheximide + Artemisinin
|
DCZT489
|
Cycloheximide
|
DD2 (Cell Line: DD2)
|
[2] |
Cycloheximide + Artemisinin
|
DCPYSX4
|
Cycloheximide
|
Hepatoblastoma (Cell Line: HB3)
|
[3] |
Cytarabine + Artemisinin
|
DCI1I1B
|
Cytarabine
|
Chronic myelogenous leukemia (Cell Line: KBM-7)
|
[2] |
Diltiazem + Artemisinin
|
DCJ93EB
|
Diltiazem
|
Hepatoblastoma (Cell Line: HB3)
|
[3] |
Doxorubicin + Artemisinin
|
DCIMWIU
|
Doxorubicin
|
Chronic myelogenous leukemia (Cell Line: KBM-7)
|
[2] |
Doxycycline + Artemisinin
|
DC985EY
|
Doxycycline
|
Hepatoblastoma (Cell Line: HB3)
|
[3] |
Dronedarone + Artemisinin
|
DC6YXZV
|
Dronedarone
|
Chronic myelogenous leukemia (Cell Line: KBM-7)
|
[2] |
Eflornithine + Artemisinin
|
DCVOXCE
|
Eflornithine
|
Chronic myelogenous leukemia (Cell Line: KBM-7)
|
[2] |
Emetine + Artemisinin
|
DCOIXFZ
|
Emetine
|
Hepatoblastoma (Cell Line: HB3)
|
[3] |
Entacapone + Artemisinin
|
DCK80N8
|
Entacapone
|
Chronic myelogenous leukemia (Cell Line: KBM-7)
|
[2] |
Fendiline + Artemisinin
|
DCNYKDU
|
Fendiline
|
DD2 (Cell Line: DD2)
|
[2] |
Fluspirilene + Artemisinin
|
DCFXT08
|
Fluspirilene
|
Chronic myelogenous leukemia (Cell Line: KBM-7)
|
[2] |
Fluspirilene + Artemisinin
|
DCQEQ0Q
|
Fluspirilene
|
DD2 (Cell Line: DD2)
|
[2] |
Fomepizole + Artemisinin
|
DCOEXXN
|
Fomepizole
|
Chronic myelogenous leukemia (Cell Line: KBM-7)
|
[2] |
GDC-0084 + Artemisinin
|
DCGH4F9
|
GDC-0084
|
Hepatoblastoma (Cell Line: HB3)
|
[3] |
GSK2126458 + Artemisinin
|
DC7SWX8
|
GSK2126458
|
Hepatoblastoma (Cell Line: HB3)
|
[3] |
Hydralazine + Artemisinin
|
DCFDC5T
|
Hydralazine
|
Chronic myelogenous leukemia (Cell Line: KBM-7)
|
[2] |
Hydroxychloroquine + Artemisinin
|
DC41WKW
|
Hydroxychloroquine
|
Chronic myelogenous leukemia (Cell Line: KBM-7)
|
[2] |
Hyodeoxycholic acid + Artemisinin
|
DC0ZFNB
|
Hyodeoxycholic acid
|
Chronic myelogenous leukemia (Cell Line: KBM-7)
|
[2] |
Iloprost + Artemisinin
|
DCATZ7K
|
Iloprost
|
Chronic myelogenous leukemia (Cell Line: KBM-7)
|
[2] |
Imatinib + Artemisinin
|
DC4I4BW
|
Imatinib
|
Chronic myelogenous leukemia (Cell Line: KBM-7)
|
[2] |
Kanamycin + Artemisinin
|
DCOGZYY
|
Kanamycin
|
Chronic myelogenous leukemia (Cell Line: KBM-7)
|
[2] |
KN-62 + Artemisinin
|
DCPGVGW
|
KN-62
|
DD2 (Cell Line: DD2)
|
[2] |
KN-62 + Artemisinin
|
DCO8R50
|
KN-62
|
Hepatoblastoma (Cell Line: HB3)
|
[3] |
L-165041 + Artemisinin
|
DCN3KXY
|
L-165041
|
Chronic myelogenous leukemia (Cell Line: KBM-7)
|
[2] |
Lacidipine + Artemisinin
|
DCLM6XU
|
Lacidipine
|
Hepatoblastoma (Cell Line: HB3)
|
[3] |
Lacosamide + Artemisinin
|
DCDEV17
|
Lacosamide
|
Chronic myelogenous leukemia (Cell Line: KBM-7)
|
[2] |
Levamisole + Artemisinin
|
DCY63MD
|
Levamisole
|
Chronic myelogenous leukemia (Cell Line: KBM-7)
|
[2] |
Loperamide + Artemisinin
|
DCTE6JU
|
Loperamide
|
Chronic myelogenous leukemia (Cell Line: KBM-7)
|
[2] |
Lumefantrine + Artemisinin
|
DC3UBZB
|
Lumefantrine
|
DD2 (Cell Line: DD2)
|
[2] |
Lumefantrine + Artemisinin
|
DC22SS8
|
Lumefantrine
|
Hepatoblastoma (Cell Line: HB3)
|
[2] |
Mebutamate + Artemisinin
|
DCJAMDX
|
Mebutamate
|
Chronic myelogenous leukemia (Cell Line: KBM-7)
|
[2] |
Mefloquine + Artemisinin
|
DC055CK
|
Mefloquine
|
Chronic myelogenous leukemia (Cell Line: KBM-7)
|
[2] |
Mefloquine + Artemisinin
|
DC6XUXQ
|
Mefloquine
|
DD2 (Cell Line: DD2)
|
[2] |
Methylene blue + Artemisinin
|
DCDVDV3
|
Methylene blue
|
DD2 (Cell Line: DD2)
|
[2] |
MK-3207 + Artemisinin
|
DCUTRV0
|
MK-3207
|
DD2 (Cell Line: DD2)
|
[2] |
ML323 + Artemisinin
|
DC69Q2O
|
ML323
|
Chronic myelogenous leukemia (Cell Line: KBM-7)
|
[2] |
Moricizine + Artemisinin
|
DC8O6DC
|
Moricizine
|
Chronic myelogenous leukemia (Cell Line: KBM-7)
|
[2] |
Naltrexone + Artemisinin
|
DCBTS07
|
Naltrexone
|
Hepatoblastoma (Cell Line: HB3)
|
[2] |
Nisoldipine + Artemisinin
|
DCDUCSZ
|
Nisoldipine
|
DD2 (Cell Line: DD2)
|
[2] |
Nitrosoglutathione + Artemisinin
|
DCEXWK5
|
Nitrosoglutathione
|
Chronic myelogenous leukemia (Cell Line: KBM-7)
|
[2] |
Norcisapride + Artemisinin
|
DC2NTG3
|
Norcisapride
|
Chronic myelogenous leukemia (Cell Line: KBM-7)
|
[2] |
NVP-AUY922 + Artemisinin
|
DCEQS4M
|
NVP-AUY922
|
Hepatoblastoma (Cell Line: HB3)
|
[3] |
Omacetaxine mepesuccinate + Artemisinin
|
DC70ZSJ
|
Omacetaxine mepesuccinate
|
DD2 (Cell Line: DD2)
|
[2] |
Omacetaxine mepesuccinate + Artemisinin
|
DC68CYR
|
Omacetaxine mepesuccinate
|
Hepatoblastoma (Cell Line: HB3)
|
[3] |
Oseltamivir + Artemisinin
|
DCP1W7H
|
Oseltamivir
|
Chronic myelogenous leukemia (Cell Line: KBM-7)
|
[2] |
Otilonium bromide + Artemisinin
|
DCK6YFW
|
Otilonium bromide
|
DD2 (Cell Line: DD2)
|
[2] |
Pazopanib + Artemisinin
|
DC9KJUY
|
Pazopanib
|
Chronic myelogenous leukemia (Cell Line: KBM-7)
|
[2] |
Pentamidine + Artemisinin
|
DCCVNUT
|
Pentamidine
|
Chronic myelogenous leukemia (Cell Line: KBM-7)
|
[2] |
Perhexiline + Artemisinin
|
DC2P7R8
|
Perhexiline
|
DD2 (Cell Line: DD2)
|
[2] |
PFK-158 + Artemisinin
|
DCLHNMZ
|
PFK-158
|
Chronic myelogenous leukemia (Cell Line: KBM-7)
|
[2] |
Phensuximide + Artemisinin
|
DCW6R72
|
Phensuximide
|
Chronic myelogenous leukemia (Cell Line: KBM-7)
|
[2] |
Piperaquine + Artemisinin
|
DCYK4QG
|
Piperaquine
|
Hepatoblastoma (Cell Line: HB3)
|
[3] |
Proparacaine + Artemisinin
|
DCOF3O6
|
Proparacaine
|
DD2 (Cell Line: DD2)
|
[2] |
Pyronaridine + Artemisinin
|
DCT18NE
|
Pyronaridine
|
DD2 (Cell Line: DD2)
|
[2] |
Pyronaridine + Artemisinin
|
DC4141M
|
Pyronaridine
|
Hepatoblastoma (Cell Line: HB3)
|
[3] |
Quinine + Artemisinin
|
DCT2NZS
|
Quinine
|
DD2 (Cell Line: DD2)
|
[2] |
Quinine + Artemisinin
|
DC32HDT
|
Quinine
|
Hepatoblastoma (Cell Line: HB3)
|
[2] |
Raltegravir + Artemisinin
|
DCQ4RDS
|
Raltegravir
|
Chronic myelogenous leukemia (Cell Line: KBM-7)
|
[2] |
Relugolix + Artemisinin
|
DC63A4D
|
Relugolix
|
DD2 (Cell Line: DD2)
|
[2] |
Sertraline + Artemisinin
|
DCNES36
|
Sertraline
|
Chronic myelogenous leukemia (Cell Line: KBM-7)
|
[2] |
Tacrolimus + Artemisinin
|
DCHK9S7
|
Tacrolimus
|
Chronic myelogenous leukemia (Cell Line: KBM-7)
|
[2] |
Teriflunomide + Artemisinin
|
DC41BNC
|
Teriflunomide
|
Chronic myelogenous leukemia (Cell Line: KBM-7)
|
[2] |
Testosterone + Artemisinin
|
DCNZS58
|
Testosterone
|
Chronic myelogenous leukemia (Cell Line: KBM-7)
|
[2] |
Tranylcypromine + Artemisinin
|
DC780XC
|
Tranylcypromine
|
Hepatoblastoma (Cell Line: HB3)
|
[2] |
Valproic Acid + Artemisinin
|
DCB2124
|
Valproic Acid
|
Chronic myelogenous leukemia (Cell Line: KBM-7)
|
[2] |
Verapamil + Artemisinin
|
DCUQIHX
|
Verapamil
|
DD2 (Cell Line: DD2)
|
[3] |
Vinblastine + Artemisinin
|
DC8QGRK
|
Vinblastine
|
Chronic myelogenous leukemia (Cell Line: KBM-7)
|
[2] |
------------------------------------------------------------------------------------ |
|
|
|
|